Citez comme : (2022, novembre) Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis. https://geertdevuyst.fr/publication/2020-garami-hyperthermia-induced-by-transient-receptor-potential-vanilloid-1-trpv1-antagonists-in-human-clinical-trials/
Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis
Article anglais Formé(e)
TitreHyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysisAuteur(s)Garami, A., Shimansky, Y. P., Rumbus, Z., Vizin, R. C. L., Farkas, N., Hegyi, J., Szakacs, Z., Solymar, M., Csenkey, A., Chiche, D. A., Kapil, R., Kyle, D. J., Van Horn, W. D., Hegyi, P., & Romanovsky, A. A.PublicationPharmacology & TherapeuticsVolume208Année de publication2020Pages107474DOIhttps://doi.org/10.1016/j.pha ... EditeurElsevier BVCitez commeGarami, A., Shimansky, Y. P., Rumbus, Z., Vizin, R. C. L., Farkas, N., Hegyi, J., Szakacs, Z., Solymar, M., Csenkey, A., Chiche, D. A., Kapil, R., Kyle, D. J., Van Horn, W. D., Hegyi, P., & Romanovsky, A. A. (2020). Hyperthermia induced by transient receptor potential vanilloid‑1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta‑analysis. Pharmacology & Therapeutics, 208, 107474. https://doi.org/10.1016/j.pharmthera.2020.107474